▁ 4.1015625
8 3.84765625
% 6.42578125
▁of 1.0693359375
▁the 2.353515625
▁residents 6.44921875
▁of 0.72802734375
▁progress 12.59375
ive 0.044403076171875
▁countries 6.578125
▁have 2.392578125
▁chron 5.88671875
ic 0.0198516845703125
▁pain 1.994140625
, 1.7626953125
▁which 2.650390625
▁is 0.72607421875
▁considered 4.5859375
▁to 1.263671875
▁be 0.044769287109375
▁an 2.58203125
▁extreme 5.44140625
▁issue 5.2734375
. 0.93505859375
<0x0A> 1.576171875
There 3.83203125
▁is 1.6396484375
▁currently 5.01171875
▁a 1.8857421875
▁severe 4.375
▁lack 1.720703125
▁of 0.0312042236328125
▁information 3.09765625
▁about 1.548828125
▁the 0.9990234375
▁effects 3.8125
▁of 0.1434326171875
▁op 3.955078125
i 3.328125
ates 0.01158905029296875
. 2.69140625
▁They 4.20703125
▁manage 8.625
▁pain 2.4140625
▁successfully 6.05078125
, 0.86328125
▁but 0.27685546875
▁the 2.60546875
▁past 9.15625
▁few 1.2763671875
▁dec 1.486328125
ades 1.9431114196777344e-05
▁indicated 8.4140625
▁the 2.533203125
▁growing 3.900390625
▁concern 3.181640625
▁regarding 2.76171875
▁op 2.076171875
iate 0.74267578125
▁ab 1.490234375
use 0.01082611083984375
▁in 3.48046875
▁forms 9.5859375
▁of 0.2269287109375
▁over 3.177734375
d 0.12042236328125
ose 0.3310546875
▁and 0.826171875
▁add 0.56884765625
iction 0.0159149169921875
. 0.10675048828125
▁A 4.6015625
▁more 5.60546875
▁manage 8.5546875
able 0.0025787353515625
▁and 2.28515625
▁sa 2.25390625
fer 8.499622344970703e-05
▁alternative 1.544921875
▁might 5.4609375
▁be 0.18408203125
▁medical 4.71484375
▁mar 0.68017578125
iju 0.0011749267578125
ana 4.9114227294921875e-05
. 0.57861328125
▁However 4.859375
, 0.01136016845703125
▁the 1.8046875
▁legal 3.58984375
▁status 1.1826171875
▁and 3.513671875
▁novel 10.4921875
ty 0.1844482421875
▁of 0.1607666015625
▁this 1.806640625
▁drug 2.10546875
▁do 4.75390625
▁not 0.02642822265625
▁allow 0.8916015625
▁finding 7.26953125
▁a 2.484375
▁large 3.64453125
▁number 0.8330078125
▁of 0.0029468536376953125
▁studies 1.0087890625
▁on 1.7451171875
▁its 1.0390625
▁effect 1.9736328125
iveness 0.158447265625
. 0.671875
▁Specifically 9.1640625
, 0.1099853515625
▁it 2.828125
▁concerns 5.28125
▁the 1.03515625
▁emot 9.6953125
ional 0.029327392578125
▁condition 5.26953125
▁of 0.62353515625
▁patients 1.0673828125
▁experien 5.71484375
cing 3.4570693969726562e-06
▁chron 0.333251953125
ic 0.0002639293670654297
▁pain 0.02764892578125
. 0.3056640625
▁This 3.552734375
▁research 2.619140625
▁paper 2.48828125
▁a 1.5380859375
ims 0.00029087066650390625
▁to 0.1435546875
▁analyze 2.716796875
▁levels 10.6328125
▁of 0.03656005859375
▁de 1.8779296875
pression 0.048980712890625
▁and 0.6494140625
▁anx 0.1234130859375
iety 0.00028252601623535156
▁among 1.4326171875
▁people 2.35546875
▁receiving 4.52734375
▁ther 5.03515625
apy 0.035003662109375
▁by 4.578125
▁comparing 10.421875
▁the 1.8779296875
▁effects 2.978515625
▁of 0.035186767578125
▁ph 5.203125
arma 0.416259765625
ce 0.0128936767578125
ut 0.0001779794692993164
ical 0.017333984375
▁op 2.048828125
io 2.54296875
ids 0.08319091796875
▁and 0.470458984375
▁MM 3.953125
. 2.23046875
<0x0A> 0.302734375
The 1.3505859375
▁data 4.18359375
▁was 1.74609375
▁collected 0.8544921875
▁and 4.0859375
▁analyz 0.60400390625
ed 0.00040650367736816406
▁in 2.107421875
▁the 1.3984375
▁form 2.494140625
▁of 0.00827789306640625
▁a 0.8427734375
▁study 3.7109375
. 2.087890625
<0x0A> 3.396484375
Direct 9.890625
▁responses 8.3828125
▁from 1.7548828125
▁a 3.220703125
▁large 4.15625
▁number 0.6103515625
▁of 0.0034694671630859375
▁participants 2.212890625
▁are 2.6015625
▁the 2.134765625
▁most 2.193359375
▁reve 7.08984375
aling 0.0011882781982421875
▁and 1.9951171875
▁inclus 8.265625
ive 0.0010356903076171875
▁type 2.919921875
▁of 0.0308074951171875
▁study 3.328125
. 0.4033203125
<0x0A> 1.4521484375
The 1.1259765625
▁analysis 4.57421875
▁of 0.9501953125
▁a 3.875
▁human 7.9609375
▁reaction 4.4453125
▁has 5.43359375
▁a 1.490234375
▁high 1.9658203125
▁potential 3.6953125
▁for 1.046875
▁bias 4.18359375
. 1.0048828125
<0x0A> 0.6318359375
The 1.1259765625
▁study 2.15625
▁included 3.751953125
▁ 0.76806640625
8 3.001953125
9 2.5859375
0 3.4453125
▁participants 1.6962890625
, 1.8701171875
▁of 3.392578125
▁which 0.3310546875
▁ 0.11297607421875
4 1.146484375
7 2.6640625
4 2.640625
▁were 1.015625
▁treated 3.080078125
▁sole 7.0234375
ly 0.00016641616821289062
▁with 0.286865234375
▁op 1.091796875
io 0.5517578125
ids 0.110107421875
, 0.63232421875
▁ 1.3798828125
3 1.16015625
2 2.33984375
9 2.494140625
▁were 1.962890625
▁treated 0.56103515625
▁with 0.50341796875
▁MM 0.7431640625
, 0.435302734375
▁and 0.1312255859375
▁ 0.1746826171875
7 2.70703125
7 0.4140625
▁were 0.80224609375
▁treated 0.43603515625
▁with 0.11053466796875
▁place 6.453125
bo 0.431396484375
. 0.251220703125
<0x0A> 1.337890625
The 0.8251953125
▁study 2.240234375
▁looked 6.47265625
▁at 0.365966796875
▁the 0.84912109375
▁inter 7.3671875
dep 3.7734375
end 0.0005893707275390625
ence 0.006114959716796875
▁of 0.529296875
▁various 4.19921875
▁factors 0.892578125
▁that 2.302734375
▁affected 4.109375
▁the 0.433349609375
▁physical 6.09765625
▁and 0.344970703125
▁emot 0.49951171875
ional 0.0001919269561767578
▁condition 1.4462890625
▁of 0.07525634765625
▁patients 1.068359375
. 0.57470703125
<0x0A> 0.71533203125
The 0.8173828125
▁question 5.31640625
na 0.94580078125
ires 0.00011038780212402344
▁used 2.197265625
▁different 7.03515625
▁variable 9.4296875
▁measures 4.0859375
▁to 1.7236328125
▁collect 3.208984375
▁information 1.8388671875
. 1.1650390625
▁For 3.748046875
▁example 0.350830078125
, 0.007228851318359375
▁it 4.46484375
▁included 1.28515625
▁compreh 9.2421875
ensive 0.0633544921875
▁so 6.78515625
cio 0.00348663330078125
- 0.397705078125
dem 0.2115478515625
ographic 0.06817626953125
▁data 0.93701171875
: 6.359375
▁gender 1.98046875
, 0.044769287109375
▁age 0.299560546875
, 0.0227508544921875
▁country 5.12109375
, 1.1572265625
▁type 4.37109375
▁of 0.045928955078125
▁residence 3.9765625
▁( 2.296875
urban 0.4755859375
/ 1.310546875
r 0.1036376953125
ural 0.0006318092346191406
), 0.268798828125
▁years 6.01953125
▁of 0.1617431640625
▁education 0.5546875
, 0.1427001953125
▁and 1.4296875
▁employ 2.08984375
ment 0.0014867782592773438
▁status 0.71826171875
. 0.1285400390625
▁Pat 5.8359375
ients 0.135498046875
▁were 0.9326171875
▁also 0.7802734375
▁asked 0.446533203125
▁about 0.912109375
▁their 0.7568359375
▁medical 2.17578125
▁history 0.357421875
▁over 8.7578125
▁the 0.056976318359375
▁years 4.78515625
▁and 1.87109375
▁the 1.46875
▁current 2.783203125
▁presence 5.30078125
▁of 0.0679931640625
▁any 2.162109375
▁severe 4.86328125
▁dise 2.087890625
ases 6.818771362304688e-05
▁such 4.4140625
▁as 0.001827239990234375
▁heart 2.59375
▁failure 1.7216796875
, 0.349609375
▁di 1.8916015625
ab 0.0008578300476074219
etes 0.00191497802734375
, 0.0887451171875
▁ar 3.978515625
th 0.156982421875
rit 0.020904541015625
is 0.004543304443359375
, 0.046630859375
▁and 1.423828125
▁so 2.400390625
▁on 0.11480712890625
. 0.0277099609375
▁The 1.876953125
▁third 6.5
▁measure 4.08203125
▁of 2.60546875
▁the 0.875
▁question 1.5751953125
naire 0.1617431640625
▁was 0.97607421875
▁indicated 11.2421875
▁by 1.09765625
▁information 6.9375
▁on 1.822265625
▁any 5.109375
▁twelve 14.1015625
- 0.138916015625
month 0.1470947265625
▁and 4.9765625
▁lifetime 0.6591796875
▁drug 2.982421875
▁and 1.728515625
▁alco 0.12432861328125
hol 6.937980651855469e-05
▁consumption 4.97265625
. 0.354248046875
▁In 3.451171875
▁addition 0.6044921875
, 0.216796875
▁the 0.998046875
▁record 9.6484375
▁included 1.4931640625
▁a 2.564453125
▁pain 3.806640625
▁measurement 4.80078125
▁scale 0.96142578125
▁from 4.4765625
▁ 0.53369140625
0 0.292724609375
▁to 0.1910400390625
▁ 0.00505828857421875
1 0.05389404296875
0 0.0240325927734375
▁to 3.888671875
▁evaluate 2.400390625
▁dis 5.921875
com 0.10919189453125
fort 0.0001646280288696289
▁feelings 8.1015625
▁during 4.28125
▁the 0.252685546875
▁last 0.93310546875
▁month 1.802734375
. 0.2098388671875
<0x0A> 0.9873046875
There 4.24609375
▁were 0.80419921875
▁a 3.111328125
▁pl 10.4921875
ur 0.1563720703125
ality 0.0005202293395996094
▁of 0.0221405029296875
▁dis 7.2421875
orders 1.4697265625
▁among 1.70703125
▁patients 1.4921875
▁in 3.171875
▁the 1.021484375
▁op 2.51953125
iate 1.3134765625
, 6.8828125
▁medical 3.701171875
▁mar 0.085693359375
iju 0.00040149688720703125
ana 9.012222290039062e-05
, 0.087646484375
▁and 0.01515960693359375
▁mixed 7.6015625
▁OP 12.0
MM 4.53125
▁groups 0.410400390625
. 0.308837890625
<0x0A> 1.7607421875
The 1.2373046875
▁high 5.86328125
▁response 7.16796875
▁rate 0.365966796875
▁is 3.083984375
▁due 3.716796875
▁to 0.011962890625
▁the 0.3779296875
▁weak 10.015625
▁focus 6.4765625
▁of 1.251953125
▁respond 5.9765625
ents 0.07623291015625
▁who 4.234375
▁have 2.984375
▁overcome 7.640625
▁severe 2.8828125
▁pain 0.9140625
▁sens 7.453125
ations 0.1641845703125
▁and 1.6591796875
▁de 4.95703125
pression 0.26318359375
. 0.64501953125
